Navigation Links
STALLERGENES : Further Profit Growth Acceleration of R&D Expenditure
Date:3/12/2008


PARIS, March 12 /PRNewswire-FirstCall/ --

- Further Profit Growth

- Sales up 16% - Profit Before R&D up 19%

- Net Profit (Group Share) up 12%

- Acceleration of R&D Expenditure The Board of Directors, meeting on 11 March 2008 under the chairmanship of Albert Saporta, approved the 2007 consolidated financial statements:

(EUR millions) 2007 As a % 2006 As a % 07/06

of sales of sales % change

Sales 147.1 100.0 126.6 100.0 16

Cost of sales (32.9) (22.3) (29.5) (23.3) 11

Gross profit 114.2 77.7 97.1 76.7 18

General, (65.1) (44.3) (55.9) (44.2) 17

administrative and

sales costs

Profit before R&D 49.1 33.4 41.2 32.5 19

Net R&D expenditure (23.8) (16.2) (18.0) (14.2) 32

Operating profit 25.3 17.2 23.2 18.3 9

(EBIT)

Net profit (Group 16.3 11.1 14.6 11.5 12

share)

Diluted earnings per EUR 1.22 EUR 1.11 10

share

Proposed dividend EUR 0.40 EUR 0.35 14

Net financial debt 10.4 (0.35) 12.0 (0.44) (14)

(x EBITDA)

Accelerated growth in 2007

Growth accelerated in all markets in 2007. The 16% sales increase reflects the vigour of sublingual route, which grew 21%, and its growing awareness among patients. Significant growth in the number of new patients confirmed growing interest in desensitisation for the treatment of allergic diseases.

This excellent sales level generated a 19% increase in profit before R&D, to EUR 49.1 million, and a 9% increase in operating profit (EBIT) to EUR 25.3 million. Net profit (Group share) was EUR 16.3 million, up 12% from the 2
'/>"/>

SOURCE Stallergenes
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. STALLERGENES: 2007: A Further Year of Strong Growth: Up 16%
2. STALLERGENES and Protein eXpert Enter Into a Partnership for Producing Mites Recombinant Allergens
3. STALLERGENES: ORALAIR Grasses: Positive Results of VO52.06 Paediatric Study
4. Stallergenes : 3rd Quarter Sales Up 17%: 9- Month Cumulative Sales Up 17%
5. STALLERGENES : Strong Business Growth: +17% and Earnings Per Share up 30%
6. MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio
7. CleveMed Receives $1.5 Million in NIH Funding to Further Develop a Portable System for Monitoring Parkinsons Disease Motor Symptoms
8. SAFC Hitech(TM) Plans Further Expansion Into Asia
9. AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment
10. Agencourt Genomic Services is Key Collaborator in New Research That Further Defines Landscape of Breast and Colon Cancers
11. Organons Asenapine Further Demonstrates Efficacy in Reducing Mania Symptoms for the Treatment of Bipolar I Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... Recognizing exciting and innovative scientific ... its 2013 Class of Young Professors. Over ... this outstanding international group with more than $824,000 ... to meet global challenges.     , The DuPont Young ... and untenured research faculty working in areas of ...
(Date:5/20/2013)... On 25-28 July, 2013, UPCP 2013 will convene ... beautiful city of lights. , According to Prof. Eddy ... medical world. Understanding and integrating genetic and molecular information ... transformation. Much of the present medical practice is based ... large cohorts that do not take into account the ...
(Date:5/20/2013)... May 20, 2013 Kitware, a leader ... tool that enables the exploration of hospital costs ... in response to the recent release of “Medicare Provider ... top 100 most-billed procedures from the Centers for Medicare ... for similar procedures at hospitals across the country has ...
(Date:5/20/2013)... In Early 2013, Dr. Ritchie ... related illnesses , announced his vision for creating a ... his protocol for treating Chronic Inflammatory Response Syndrome (CIRS). ... to achieve certification in the Shoemaker Protocol. , ... the Shoemaker Protocol in other parts of the country, ...
Breaking Biology Technology:DuPont Celebrates Scientific Innovation by Recognizing Young Professors 2DuPont Celebrates Scientific Innovation by Recognizing Young Professors 3The International Congress on Personalized Medicine - Up Close and Personalized 2013 in Paris 2Kitware Enables Interactive Exploration of CMS Medicare Data 2Dr. Ritchie Shoemaker Certifies Third Physician in His Treatment Protocol for Chronic Inflammatory Response Syndrome (CIRS) 2
... Fiserv Inc. has unveiled a program of healthcare ... processing and health-plan administration. , ,Spurred on ... banking is a set of services which includes ... payments between parties in healthcare transactions. , ...
... The increased use of clinical technologies in healthcare does ... for care decisions, particularly when technology vendors include strong ... developers market their products more directly to consumers, they ... attendees of the recent Digital Healthcare Conference ...
... events, is coming to Milwaukee again on June 22 and 23 ... both global and Wisconsin-area technology companies. , ,The conference will feature ... Networks , Agilent , EqualLogic , Inacom , ... Runner Business Class and other companies. , ,Attendees will have ...
Cached Biology Technology:Liability issues not seen as roadblock to healthcare technology advancements 2Liability issues not seen as roadblock to healthcare technology advancements 3
(Date:5/19/2013)... reports that white men and women of European descent ... and lesser toe deformities, including hammer or claw toe. ... the heritability of foot disorders in humansappear in ... Wiley on behalf of the American College of Rheumatology ... as 60% of older adults have foot disorders which ...
(Date:5/19/2013)... electricity-producing bacteria that can grow using hydrogen gas as ... sole source of carbon. Researchers at the University ... General Meeting of the American Society for Microbiology. , ... on hydrogen," says Amit Kumar, a researcher on the ... the Lovley Lab Group at the university. , Under ...
(Date:5/19/2013)... of California, Davis have engineered a strain of photosynthetic ... They report their findings today at the 113th General ... this work, we used synthetic biology approaches to probe ... light energy for growth) cyanobacterial metabolism for the ability ... lead researcher on the study. He is part ...
Breaking Biology News(10 mins):Blame your parents for bunion woes 2
... research at the University of Haifa, Israel, has made a ... of white blood cells that play a role in the ... discovered can assist in the development of drugs that are ... human body, unlike most of the existing drugs that attempt ...
... key gene mutation responsible for type 2 diabetes in nearly ... study, which originated in Italy and was validated at UCSF, ... major drop in the body,s ability to make insulin receptors ... to absorb sugar. This drop in insulin receptors leads to ...
... This press release is available in German . ... of time, show changes in their mechanical properties. The exact ... However, the microscopic structure and the complexity of the systems ... team led by Professor Andreas Bausch from the Chair of ...
Cached Biology News:How much can a cell uptake? 2How much can a cell uptake? 3Type 2 diabetes linked to single gene mutation in 1 in 10 patients 2
activating transcription factor 4 (tax-responsive enhancer element B67),...
Reactivity: Human...
... fosmid (40kb), and large plasmid insert (10-20kb) ... BAC vector. On command 20-50 fold copy ... DNA purification. Available with blue-white screening (pEZ ... the highest insert stability. Kits include electrocompetent ...
... Error-free cloning of BAC (100+kb), fosmid (40kb), ... insert stability than any othe BAC vector. ... high yields and easy recombinant DNA purification. ... transcription-free (pSMART VC) vectors for the highest ...
Biology Products: